Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

Shionogi acquires JT Group's pharmaceutical business

Shionogi's acquisition of JT Group's pharmaceutical business. Photo shows, from left, Koji Shimayoshi , Executive Vice President and Representative Director of JT, Isao Teshirogi, Chairman, President and CEO of Shionogi, and Nobumasa Kondo, President and Representative Director of Torii Pharmaceuticals.=May 7,2025,Tokyo

E

Shionogi acquires JT Group's pharmaceutical business

Shionogi's acquisition of JT Group's pharmaceutical business. Photo shows, from left, Koji Shimayoshi , Executive Vice President and Representative Director of JT, Isao Teshirogi, Chairman, President and CEO of Shionogi, and Nobumasa Kondo, President and Representative Director of Torii Pharmaceuticals.=May 7,2025,Tokyo

E

Shionogi acquires JT Group's pharmaceutical business

Shionogi's acquisition of JT Group's pharmaceutical business. Photo shows Isao Teshirogi, Chairman, President and CEO of Shionogi.=May 7,2025,Tokyo

E

Shionogi acquires JT Group's pharmaceutical business

Shionogi's acquisition of JT Group's pharmaceutical business. Photo shows, from left, Koji Shimayoshi , Executive Vice President and Representative Director of JT, Isao Teshirogi, Chairman, President and CEO of Shionogi, and Nobumasa Kondo, President and Representative Director of Torii Pharmaceuticals.=May 7,2025,Tokyo

E

Paris Olympics: Football

Assistant referee Naomi Teshirogi (R) of Japan reacts during a Paris Olympic men's football Group C match between Egypt and the Dominican Republic at la Beaujoire Stadium in Nantes, France, on July 24, 2024.

E

Football: FIFA Women's World Cup

Referees (orange, from L) Naomi Teshirogi, Ivana Martincic, Yoshimi Yamashita and Makoto Bozono shake hands with New Zealand and Norway players ahead of the opening match of the FIFA Women's World Cup football tournament at Eden Park in Auckland, New Zealand, on July 20, 2023.

E

Football: FIFA Women's World Cup

Referees (orange, from L) Naomi Teshirogi, Ivana Martincic, Yoshimi Yamashita and Makoto Bozono line up ahead of the opening match of the FIFA Women's World Cup football tournament between New Zealand and Norway at Eden Park in Auckland, New Zealand, on July 20, 2023.

E

Shionogi to buy U.S. pharmaceutical firm Sciele Pharma

TOKYO, Japan - Isao Teshirogi (R), president of Japanese drug manufacturer Shionogi & Co., poses with Patrick Fourteau, chief executive of Sciele Pharma Inc., at a news conference in Tokyo on Sept. 1, in which Shionogi announced that it will launch a $1.1 billion friendly offer for shares in the Atlanta-based U.S. pharmaceutical company in order to establish a sales base in the United States.

E

Japanese drugmaker Shionogi's president

Isao Teshirogi (C), president of Japanese pharmaceutical firm Shionogi & Co., attends a press conference in Tokyo on March 4, 2022, over the company's COVID-19 vaccine under development.

E

Japanese drugmaker Shionogi's president

Isao Teshirogi, president of Japanese pharmaceutical firm Shionogi & Co., attends a press conference in Tokyo on March 4, 2022, over the company's COVID-19 vaccine under development.

E

Shionogi to buy U.S. pharmaceutical firm Sciele Pharma

TOKYO, Japan - Isao Teshirogi (R), president of Japanese drug manufacturer Shionogi & Co., poses with Patrick Fourteau, chief executive of Sciele Pharma Inc., at a news conference in Tokyo on Sept. 1, in which Shionogi announced that it will launch a $1.1 billion friendly offer for shares in the Atlanta-based U.S. pharmaceutical company in order to establish a sales base in the United States. (Kyodo)

E

2 Japanese picked as referees at 2015 FIFA Women's World Cup

Sachiko Yamagishi (L) and Naomi Teshirogi receive congratulatory flowers in Marugame, Kagawa Prefecture, western Japan, on May 24, 2015, for their selection as referee and assistant referee, respectively, at the 2015 FIFA Women's World Cup in Canada between June and July. (Kyodo) ==Kyodo

E

Drugmaker Shionogi testing coronavirus vaccine candidate

Isao Teshirogi, president of Japanese pharmaceutical maker Shionogi & Co., gives an interview in Osaka on Dec. 16, 2020. Shionogi has conducted clinical testing for its coronavirus vaccine candidate.

E

Drugmaker Shionogi testing coronavirus vaccine candidate

Isao Teshirogi, president of Japanese pharmaceutical maker Shionogi & Co., gives an interview in Osaka on Dec. 16, 2020. Shionogi has conducted clinical testing for its coronavirus vaccine candidate.

E

Drugmaker Shionogi testing coronavirus vaccine candidate

Isao Teshirogi, president of Japanese pharmaceutical maker Shionogi & Co., gives an interview in Osaka on Dec. 16, 2020. Shionogi has conducted clinical testing for its coronavirus vaccine candidate.